Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nuwellis, Inc.CHFS · Entity 8478 | Chief Commercial Officer | January 03, 2018 | January 05, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nuwellis, Inc.
Report date January 03, 2018 · Filed January 05, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Incentive Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.50 · Expires 2028-01-03 | Direct | 181,068 |
Reported balance
After 2018-01-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-01-03 · Grant · Acquired 181,068 · Balance 181,068 F1: The options will vest as follows: 25% of the options will vest on the one-year anniversary of the date of grant; the remaining options will vest in 36 equal consecutive monthly increments thereafter, so that all of the options will be vested on the four-year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options will vest as follows: 25% of the options will vest on the one-year anniversary of the date of grant; the remaining options will vest in 36 equal consecutive monthly increments thereafter, so that all of the options will be vested on the four-year anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2018 Filed Jan 5, 2018 21:12 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantIncentive Stock Option (right to buy) · Derivative | 181,068 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001596771-18-000001 · primary_doc.xml · derivative · entry 1 Breidenstein Jim · CIK 0001705206 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,068 Underlying: Common Stock · 181,068 shares Expires 2028-01-03 F1 · derivative.exercise_date: The options will vest as follows: 25% of the options will vest on the one-year anniversary of the date of grant; the remaining options will vest in 36 equal consecutive monthly increments thereafter, so that all of the options will be vested on the four-year anniversary of the date of grant. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:06 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNon-qualified Stock Option (right to buy) · Derivative | 339,145 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001596771-17-000049 · primary_doc.xml · derivative · entry 1 Breidenstein Jim · CIK 0001705206 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,145 Underlying: Common Stock · 339,145 shares Expires 2027-06-01 F1 · derivative.exercise_date: The options will vest as follows: 25% of the options will vest on the one-year anniversary of the date of grant; the remaining options will vest in 36 equal consecutive monthly increments thereafter, so that all of the options will be vested on the four-year anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.